en
E-mail us
(925) 558-5040
bd_global@crystalpharmatech.com
 cn
cn
Showing 27 out of 27 results
A Significant Step Toward Greater Clarity in Polymorph Control for Innovative Drugs
News
A Significant Step Toward Greater Clarity in Polymorph Control for Innovative Drugs
28 Jan 2026
Brise Pharma Presents“Best Partner”Trophy to Crystal Formulation Services, Recognizing Their Excellence in Drug Product CDMO Services
News
Brise Pharma Presents“Best Partner”Trophy to Crystal Formulation Services, Recognizing Their Excellence in Drug Product CDMO Services
04 Dec 2025
Crystal Pharmatech Receives CNAS Reaccreditation, Scope Expansion, and Address Approval
News
Crystal Pharmatech Receives CNAS Reaccreditation, Scope Expansion, and Address Approval
11 Aug 2025
Crystal Pharmatech and Divamics Announce Strategic Collaboration to Accelerate Drug Development through AI, Crystal Form, and Formulation Innovation
News
Crystal Pharmatech and Divamics Announce Strategic Collaboration to Accelerate Drug Development through AI, Crystal Form, and Formulation Innovation
09 May 2025
Improving the Manufacture of mRNA Biologics
News
Improving the Manufacture of mRNA Biologics
13 Nov 2024
Crystal Bio Appoints Dr. Ye Gu as Co-founder, CTO, and Head of USA BD
News
Crystal Bio Appoints Dr. Ye Gu as Co-founder, CTO, and Head of USA BD
14 May 2024
CATUG and Crystal Bio Establish Strategic Partnership, Launching “CATUG-Crystal” Joint Lab Dedicated to Advanced Nucleic Acid Analytical Services
News
CATUG and Crystal Bio Establish Strategic Partnership, Launching “CATUG-Crystal” Joint Lab Dedicated to Advanced Nucleic Acid Analytical Services
21 Feb 2024
Dr. LianFeng Huang Joins Crystal Pharmatech as Chief Scientist
News
Dr. LianFeng Huang Joins Crystal Pharmatech as Chief Scientist
25 Jan 2024
Crystal Pharmatech's CDMO Business Unit - Crystal Formulations Services Successfully Passed EU QP Audit
News
Crystal Pharmatech's CDMO Business Unit - Crystal Formulations Services Successfully Passed EU QP Audit
22 Jan 2024
Crystal Bio Welcomes Dr. Shiaw-Lin (Billy) Wu as Co-Founder and Chief Scientific Officer
News
Crystal Bio Welcomes Dr. Shiaw-Lin (Billy) Wu as Co-Founder and Chief Scientific Officer
19 Jan 2024
Crystal Formulation Services successfully passed the dual certification of GMP and GDP conducted by SGS
News
Crystal Formulation Services successfully passed the dual certification of GMP and GDP conducted by SGS
07 Nov 2023
Crystal Pharmatech Recognized as
News
Crystal Pharmatech Recognized as "Best Partner" by Allorion Therapeutics for Excellent Services
07 Jul 2023
Crystal Formulation Services' GMP Manufacturing Facility Successfully Passes the Remote Audit by US Client, Marking a Key Milestone for Its International Expansion
News
Crystal Formulation Services' GMP Manufacturing Facility Successfully Passes the Remote Audit by US Client, Marking a Key Milestone for Its International Expansion
12 May 2023
Crystal Pharmatech's CDMO Business Unit - Crystal Formulation Services Received China Drug Product Manufacturing License, Achieving the Important Milestone in Formulation Capability
News
Crystal Pharmatech's CDMO Business Unit - Crystal Formulation Services Received China Drug Product Manufacturing License, Achieving the Important Milestone in Formulation Capability
27 Mar 2023
Candoo's Formulation Technology Platform Featured in the Drug Development & Delivery Journal
News
Candoo's Formulation Technology Platform Featured in the Drug Development & Delivery Journal
09 Mar 2023
Industry Shift: FDA Goes Vegan?
News
Industry Shift: FDA Goes Vegan?
22 Feb 2023
Crystal Pharmatech Returned to AAPS 2022 PharmSci 360
News
Crystal Pharmatech Returned to AAPS 2022 PharmSci 360
25 Oct 2022
Crystal Formulation Services（CFS）Opens New Formulation Development Center and Analytical R&D Lab in Suzhou, China
News
Crystal Formulation Services（CFS）Opens New Formulation Development Center and Analytical R&D Lab in Suzhou, China
29 May 2022
Crystal Formulation Services, Formulation Tailor-made for Your Molecules
News
Crystal Formulation Services, Formulation Tailor-made for Your Molecules
22 Apr 2022
Candoo Enables the Successful Development of a BCS 4 Combo Drug Product
News
Candoo Enables the Successful Development of a BCS 4 Combo Drug Product
14 Jan 2022
Crystal Pharmatech Expands Leadership Team
News
Crystal Pharmatech Expands Leadership Team
04 Jun 2020
International Company Crystal Pharmatech Finds CCIT An Optimal Spot for First US Location
News
International Company Crystal Pharmatech Finds CCIT An Optimal Spot for First US Location
04 Aug 2017
Crystal Pharmatech Raises $10 Million to Accelerate Growth
News
Crystal Pharmatech Raises $10 Million to Accelerate Growth
22 Sep 2015
Crystal Pharmatech Triples Headquarters in Biobay, China, with More Floors and Labs
News
Crystal Pharmatech Triples Headquarters in Biobay, China, with More Floors and Labs
17 Aug 2013
Crystal Pharmatech and Particle Sciences Form a US-China Pharmaceutical CRO Partnership
News
Crystal Pharmatech and Particle Sciences Form a US-China Pharmaceutical CRO Partnership
04 Mar 2013
Xceleron and Crystal Pharmatech Announce Partnership to Improve Early Clinical Development Utilizing Absolute Bioavailability Trials and Solid-State Solutions
News
Xceleron and Crystal Pharmatech Announce Partnership to Improve Early Clinical Development Utilizing Absolute Bioavailability Trials and Solid-State Solutions
22 Jan 2013
Crystal Pharmatech Introduces Customized Service Packages for Customers Seeking Materials Science Approaches in Drug Discovery and Development
News
Crystal Pharmatech Introduces Customized Service Packages for Customers Seeking Materials Science Approaches in Drug Discovery and Development
12 Dec 2012
Small Molecule
Mol2Med™ Integrated Services Developability Assessment API Form and Solid-State Research Crystallization Development Services Pre-formulation Studies Formulation and Analytical Development GMP Manufacturing Clinical Supply
Crystal Bio Solutions
Biologics Characterization and CMC Analytics Bioanalytical and Biomarker Services Quantitative Clinical Pharmacology (QCP)
Crystal NAX
DNA Synthesis RNA Synthesis LNP Formulation Services Analytical & Characterization Services Early-Phase Manufacturing Catalogue Products
Technology
Solid Form Screening Solid Form Developability Evaluation Absolute Structure Determination Crystallization Process Development Conventional Oral Solid Dosage Forms Bioavailability Enhancement for Insoluble Compounds & PROTAC & Oral Peptides Mini-tablet
Quick Links
Highlights News Events Knowledge Hub Webinar Series
Contact Us
bd_global@crystalpharmatech.com (925) 558-5040
U.S
NJ Sites: Suite 500-B, 3000 Eastpark Blvd, Cranbury, New Jersey, USA 08512

2005 Eastpark Blvd, Cranbury, New Jersey, USA 08512

CA Site: 7133 Koll Center Parkway, Suite 200, Pleasanton, California, USA 94566
Canada
6800 Kitimat Rd, Unit 1, Mississauga, Ontario, Canada L5N 5M1
China
No. 288, Jiangyun Road, Suzhou Industrial Park, Suzhou, China 215123

Subscribe to be the first to get the updates!

Subscribe to be the first to get the updates!
Privacy Policy
Sitemap
Small Molecule
Mol2Med™ Integrated Services Developability Assessment API Form and Solid-State Research Crystallization Development Services Pre-formulation Studies Formulation and Analytical Development GMP Manufacturing Clinical Supply
Crystal Bio Solutions
Biologics Characterization and CMC Analytics Bioanalytical and Biomarker Services Quantitative Clinical Pharmacology (QCP)
Technology
Quick Links
About Us Events
NJ Sites: Suite 500-B, 3000 Eastpark Blvd, Cranbury, New Jersey, USA 08512

2005 Eastpark Blvd, Cranbury, New Jersey, USA 08512

CA Site: 7133 Koll Center Parkway, Suite 200, Pleasanton, California, USA 94566
bd_global@crystalpharmatech.com (925) 558-5040
Privacy Policy
Sitemap